605507.SS
605507.SS
CNE100004NS2
GUOBANG PHARMA LTD
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 6.011.397.499 5.890.839.206
2.0%
Cost of Revenue 4.446.532.644 4.418.112.642
0.6%
Gross Profit 1.564.864.855 1.472.726.564
6.3%
602.982.982 587.645.874
2.6%
Operating Income 961.881.873 885.080.690
8.7%
Pretax Income 951.259.912 887.969.784
7.1%
Net Income Common Stockholders 820.820.433 781.595.426
5.0%
-- --
--
-- --
--
ende